@article {2185, title = {A Comparative Study of CFA and MIA Induction Models in Rat Knee Arthritis}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {December 2023}, pages = {1197-1201}, type = {Research Article}, chapter = {1197}, abstract = {

This study presents another comparative review of knee joint arthritis induction in rats using two distinct methods: Complete Freund{\textquoteright}s Adjuvant (CFA) and monosodium iodoacetate (MIA). Different variables are assessed, including bodyweight changes, knee bend scores, and knee diameter measurements, as well as the quantification of interleukin-1β (IL-1β) and C-telopeptide of type II collagen (CTX-II) levels. CFA or MIA induction was used on rats, and 14 days were observed. Our data show that the impact of arthritis induction varies significantly across the two models. Both the CFA and MIA groups showed different changes in terms of bodyweight changes, knee bend scores, and knee diameter variations. Furthermore, the levels of IL-1β and CTX-II, both known indicators of inflammation and cartilage degeneration, were measured. Notably, IL-1β levels in the CFA group were considerably higher than in the MIA-induced rats, although CTX-II concentrations showed a contrary pattern. These findings highlight the need to carefully consider the induction approach when performing arthritis investigations in rats since the model used has a major impact on the reported physiological alterations. This study{\textquoteright}s comparative analysis provides useful information for researchers looking to use rat knee joint arthritis models, laying the groundwork for a better-informed selection of the best induction strategy depending on desired outcome metrics.

}, keywords = {CFA, CTX-II, IL-1β, MIA, Osteoarthritis}, doi = {10.5530/pj.2023.15.217}, author = {Rena Normasari and Bambang Purwanto and Damayanti Tinduh} } @article {2027, title = {Effects of Magnesium Supplementation on Kidney Function and Phosphate Levels in Children with Chronic Kidney Disease and Hyperphosphatemia: A Double-blind Randomized Clinical Trial}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {June 2023}, pages = {253-257}, type = {Original Article }, chapter = {253}, abstract = {

Background: Pediatric patients with chronic kidney disease (CKD) who have hyperphosphatemia may experience further deterioration in kidney function. This study aims to investigate the effect of magnesium supplementation on the reduction of phosphate levels and improvement of kidney function in children with CKD and hyperphosphatemia, compared to a placebo. Methods: A randomized, double-blind, placebocontrolled trial was conducted at Pediatric Ward in our setting during March-July 2022. We compared oral magnesium supplementation (6 mg/kg body weight/day for two months) with a placebo in children with CKD and hyperphosphatemia (ages 1-18 years old). Patients who were on dialysis and had serum magnesium levels of \<1.6 mg/dL and \>2.4 mg/dL, and were allergic to magnesium supplementation were excluded. A paired T-test and the Wilcoxon signed-rank test were used for statistical analysis. Results: We collected 31 children in the experimental group and 29 children in the placebo group. Phosphate levels were decreased in both the magnesium supplementation and placebo groups (5.4 {\textpm} 0.9 to 4.8 {\textpm} 1.1 mg/dL; p-value = 0.001 and 5.1 {\textpm} 0.6 to 4.3 {\textpm} 1.2 mg/dL; p-value=0.003). However, when compared between groups, the reductions were not significantly different (0.7 vs 0.8; p-value=0.935). A significant improvement was found in kidney function in both groups using estimated Glomerular Filtration Rate (eGFR) (83.4{\textpm}25.3 to 118.8{\textpm}52; p-value=\<0.001 and 86.3{\textpm}28.1 to 96.9 {\textpm} 35.8; p-value=0.004), and the reductions were significantly different (35.4 vs 10.7; p-value=0.045). Conclusion: Magnesium supplements have considerably lower phosphate levels and markedly improved kidney function in children with CKD and hyperphosphatemia.

}, keywords = {Children, Chronic Kidney Disease, Hyperphosphatemia, Kidney Function., Magnesium}, doi = {10.5530/pj.2023.15.71}, author = {Glabela Christiana Pandango and Bambang Purwanto and Risky Vitria Prasetyo} } @article {1798, title = {Effects of High Intensity Swimming on Heat Shock Protein 70, Superoxide Dismutase and Malondialdehyde of Rattus norvegicus Male Rats}, journal = {Pharmacognosy Journal}, volume = {14}, year = {2022}, month = {June 2022}, pages = {524-530}, type = {Original Article}, chapter = {524}, abstract = {

Introduction: This study aims to analyze relationship between physical activity with high intensity swimming by proving the difference in the mean levels of HSP-70, SOD levels and MDA levels in male white rats (Rattus norvegicus) who perform vigorous-intensity physical activity compared to male white rat (Rattus norvegicus) who do not engage in strenuous physical activity. Method: This research is a laboratory experimental research. This research is a True Experimental Research type that uses a Post Test Only Control Group Design research design. The experimental unit consisted of 28 white rats (Rattus norvegicus). The study was started by dividing the rats into 2 groups. Group 0 who did not receive heavy physical activity treatment and group 1 who received heavy intensity physical activity treatment 3 times a week for 4 weeks. Results: The results of the Shapiro-Wilk test showed that the HSP-70 data were normally distributed (p\<0.05). SOD and MDA data for all groups were normally distributed (p\>0.05). The results of the Kruskal Wallis test showed that there was a significant difference in HSP-70 between groups (p \> 0.05), the results of the Mann Whitney test showed that the HSP-70 of the K0 group was significantly different from the K1 group. The results of the analysis of variance with Brown-Forsythe showed that there was a significant difference in SOD between groups (p \< 0.05). The results of the Games Howell test showed that the SOD of group K0 was significantly different from that of group K1. The results of the analysis of variance showed that there was a significant difference in MDA between groups (p \< 0.05). The results of the LSD test showed that the MDA of the K0 group was significantly different from the K1 group. Conclusion: There is a difference in the mean levels of HSP-70 in white male rat (Rattus norvegicus) whoperform strenuous physical activity, lower than male white rat (Rattus norvegicus) who do not engage in strenuous physical activity. There is a difference in the mean SOD levels in male white rat (Rattus norvegicus) which perform strenuous physical activity, lower than male white rat (Rattus norvegicus) who do not do strenuous physical activity. There is a difference in the mean MDA levels in male white rat (Rattus norvegicus) after doing strenuous physical activity, higher than male white rat (Rattus norvegicus) who do not engage in strenuous physical activity.

}, keywords = {HSP-70, MDA., SOD, Strenuous physical activity}, doi = {10.5530/pj.2022.14.66}, author = {Dody Taruna and Bambang Purwanto and Harianto Notopuro and Widjiati and Budi Utomo and Lilik Herawati and Reny I{\textquoteright}tishom and Aryati} } @article {1907, title = {The Effects of Leaves Extract of Toddalia aculeata on Body Weight, Body Mass Index, Body Fat Content and Resistive Index in Male Rats with High-Fat Diet}, journal = {Pharmacognosy Journal}, volume = {14}, year = {2022}, month = {December 2022}, pages = {771-777}, type = {Original Article}, chapter = {771}, abstract = {

Introduction: Dictamine is found in the Toddalia aculeata plant and is able to interact with Flavin- Containing Monooxygenase-3 (FMO3) in silico, which mediates endogenous atherosclerosis formation. Therefore, this study aimed to investigate the effects of T. aculeata extract (TAE) administration on Body Weight (BW), Body Mass Index (BMI), Body Fat Content (BFC), and Resistive Index (RI) in rats with a high-fat diet. Methods: Forty male Sprague-Dawley rats were randomly divided into the negative control (NC), positive control (PC) + 2.98 μg/kg BW dictamine and treatment (TAE1-3) + 200, 400, and 800 mg/ kg BW TAE respectively. All rats were given a high-fat diet (HFD) for 28 days. The data were analyzed statistically using one-way ANOVA, repeated-measured ANOVA, and Friedman{\textquoteright}s tests with p\<0.05. Results: The average of rats{\textquoteright} BW in TAE2 (270{\textpm}13.78 g) and TAE3 (276.62{\textpm}40.31 g) was lower than that of the NC (304.12{\textpm} 4.16 g) but only the TAE2 group was significantly different (p=0.032). Rats in the TAE 1-3 groups had the average BMI (26.03{\textpm}5.61; 21.84{\textpm}0.81; 20.78{\textpm}2.17 g/cm3) significantly lower than the NC (29.61{\textpm}2.28 g/cm3) and the PC (28.67{\textpm}1.68 g/cm3) for TAE2 and 3. The same pattern was also observed in BFC. All treatment groups had significantly lower RI compared to the NC group (0.62{\textpm}0.07 cm). Conclusion: Administration of 400 and 800 mg/kg BW TAE for 28 days decreases BW, BMI, BFC, and RI in rats with a high-fat diet. Dictamine in the ethanol extract of T. aculeata leaves might contribute to the reduction of RI in rats with a high-fat diet.

}, keywords = {Body Fat Content, Body Mass Index, Obesity, Resistive Index, Toddalia Aculeata Extract.}, doi = {10.5530/pj.2022.14.166}, author = {Prasetyo Sarwono Putro and Dono Indarto and Bambang Purwanto and Widyastuti Soewondo and Sulistyani Kusumaningrum and Khim Yatul Nguzum} }